Intero Biosystems wants drugmakers to test on mini human intestines, not animals

By Kate Park · TechCrunch · Wednesday, 14 October 2026 at 23:00 (1h ago) · Original article ↗

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

You're reading a preview. The full article is published by TechCrunch on their website.

Read the full story on TechCrunch

Business

CedarDB wants one database to handle both transactions and analytics, as AI agents raise the stakes

Databases have traditionally been designed either for analytical data or for operational data. But database engine CedarDB supports both, and its approach has gained relevance with the rise of agentic AI.

TechCrunch 2h ago

Business

Ambani’s Jio seeks to raise $3.2B in what could be India’s biggest IPO

Jio plans to use most of its IPO proceeds to repay debt as it expands beyond telecom.

TechCrunch 2h ago

Business

AT&T is selling its Mexican business for $2 billion

AT&T has been one of Mexico's biggest carriers for over a decade, but that's about to come to an end. The company has announced that it has reached an agreement to sell AT&T Mexico to Grupo Televisa and Fintech Holdings for $2 billion in cash at closing, "subject to certain…

GSMArena 3h ago

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

More Business & Startups

CedarDB wants one database to handle both transactions and analytics, as AI agents raise the stakes

Ambani’s Jio seeks to raise $3.2B in what could be India’s biggest IPO

AT&T is selling its Mexican business for $2 billion